Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.53 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.53 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.47 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.47 |
| ▸ | MMP2 | P08253 | 2/20 | 0.47 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | FDPS | P14324 | 3/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7605379 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL5181134 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL5180295 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL7612414 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL5180613 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL5178692 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL2515904 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL9324206 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL5180208 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL2513516 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 243 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113960235-B | Application and method of biomarker in preparation of lung cancer detection reagent | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 2023-03-14 | — | — | CN | claimed |
| CN-113960235-A | Application and method of biomarker in preparation of lung cancer detection reagent | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 2022-01-21 | — | — | CN | claimed |
| US-20150125933-A1 | PRODUCTION OF FATTY ACIDS AND DERIVATIVES THEREOF HAVING IMPROVED ALIPHATIC CHAIN LENGTH AND SATURATION CHARACTERISTICS | LS9, INC. (US) | 2015-05-07 | — | — | US | claimed |
| EP-2739726-A1 | PRODUCTION OF FATTY ACIDS AND DERIVATIVES THEREOF HAVING IMPROVED ALIPHATIC CHAIN LENGTH AND SATURATION CHARACTERISTICS | LS9, Inc. (US) | 2014-06-11 | — | — | EP | claimed |
| EP-1974720-B1 | Use of a vitreoscilla filiformis lipopolysaccharide fraction as an agent for stimulating the synthesis of anti-microbial skin peptides | OREAL (FR) | 2013-02-13 | — | — | EP | claimed |
| WO-2013019647-A1 | PRODUCTION OF FATTY ACIDS AND DERIVATIVES THEREOF HAVING IMPROVED ALIPHATIC CHAIN LENGTH AND SATURATION CHARACTERISTICS | LS9, INC. (US) | 2013-02-07 | — | — | WO | claimed |
| US-20100170826-A1 | PROCESS FOR PRODUCING LOW MOLECULAR WEIGHT HYDROCARBONS FROM RENEWABLE RESOURCES | LS9, INC. (US) | 2010-07-08 | — | — | US | claimed |
| US-7727973-B2 | Lipid A-type compound and composition containing it | L'OREAL (FR) | 2010-06-01 | — | — | US | claimed |
| EP-2116552-A2 | Peptides, derivatives thereof, process for producing the same, strain producing the same, and antiviral agent comprising the same as active ingredient | Toyo Suisan Kaisha, Ltd. (JP) | 2009-11-11 | — | — | EP | claimed |
| US-20090035294-A1 | LIPOPOLYSACCHARIDE FRACTIONS OF VITREOSCILLA FILIFORMIS USEFUL FOR STIMULATING THE SYNTHESIS OF ANTI-MICROBIAL PEPTIDES OF THE SKIN | L'OREAL (FR) | 2009-02-05 | — | — | US | claimed |
| WO-2008113041-A2 | PROCESS FOR PRODUCING LOW MOLECULAR WEIGHT HYDROCARBONS FROM RENEWABLE RESOURCES | LS9, INC. (US) | 2008-09-18 | — | — | WO | claimed |
| EP-1531158-B1 | Lipid A and topic, in particular cosmetic, composition thereof | OREAL (FR) | 2006-09-13 | — | — | EP | claimed |
| US-20050118118-A1 | Lipid A-type compound and composition containing it | L'OREAL (FR) | 2005-06-02 | — | — | US | claimed |
| US-20040102605-A1 | Novel peptides, derivatives thereof, process for producing the same, novel strain producing the same, and antiviral agent comprising the same as active ingredient | TOYO SUISAN KAISHA, LTD. (JP) | 2004-05-27 | — | — | US | claimed |
| EP-1369426-A1 | PEPTIDES, DERIVATIVES THEREOF, PROCESS FOR PRODUCING THE SAME, STRAIN PRODUCING THE SAME, AND ANTIVIRAL AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT | Toyo Suisan Kaisha, Ltd. (JP) | 2003-12-10 | — | — | EP | claimed |
| EP-0466838-B1 | NOVEL LIPID A DERIVATIVES AND USES THEREFOR | WISCONSIN ALUMNI RES FOUND (US) | 1998-04-01 | — | — | EP | claimed |
| EP-0310005-B1 | Process for modifying the microbial cleansing of soil contaminated with hydrocarbons, in particular with mineral oils, by microbial oxidation | WINTERSHALL AG (DE) | 1993-11-24 | — | — | EP | claimed |
| US-5128262-A | Biosurfactant | WINTERSHELL AG (DE) | 1992-07-07 | — | — | US | claimed |
| CN-112912383-B | Peptide compounds | 优拓制药公司 | 2024-07-05 | — | — | CN | disclosed |
| US-4059630-A | Anti-androgenic steroids | THE JOHNS HOPKINS UNIVERSITY (US) | 1977-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102605-A1 | Novel peptides, derivatives thereof, process for producing the same, novel strain producing the same, and antiviral agent comprising the same as active ingredient | PELP1, GLUL, SARS1 | GPR84 1975/4885FFAR1 2783/4885FFAR4 1687/4885 |
| US-20090035294-A1 | LIPOPOLYSACCHARIDE FRACTIONS OF VITREOSCILLA FILIFORMIS USEFUL FOR STIMULATING THE SYNTHESIS OF ANTI-MICROBIAL PEPTIDES OF THE SKIN | CUTA, LRBA, LTA | GPR84 1219/4885FFAR1 357/4885FFAR4 284/4885 |
| US-20050118118-A1 | Lipid A-type compound and composition containing it | CUTA, PLIN1, PLIN5 | GPR84 555/4885FFAR1 183/4885FFAR4 185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.